Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs boostAGErx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and boostAGErx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 125 · Grade C

boostAGErx

Visit boostAGErx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make boostAGErx a bad call — it's best for readers who want to check the clinical and pharmacy arrangements and can obtain an itemized medication-and-membership total. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
72
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
74
Track Record
88
68
CoreAge RxBrief Score 94 · 72boostAGErx

Price, coverage & the tracker

CoreAge RxboostAGErx
Brief Score94/100 (A)72/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm complete charge

GLP-1 formulation and full charge unconfirmed; terms use a 28-day membership cycle. Earlier $95 observation is historical.

Full price details

Current semaglutide formulation and medication-plus-membership quote unknown; earlier listing: From $95/mo (billed every 28 days, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm complete charge

GLP-1 formulation and full charge unconfirmed; terms use a 28-day membership cycle. Earlier $145 observation is historical.

Full price details

Current tirzepatide formulation and medication-plus-membership quote unknown; earlier listing: From $145/mo (billed every 28 days, compounded)

CoverageUS only; restrictions by state, confirmed at intakeTerms advertise all 50 states plus DC for adults physically in the US; clinical and pharmacy eligibility applies
Brand-name accessNot confirmedBrand or compounded formulation unconfirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

boostAGErx: Current GLP-1 formulations and full charges remain unconfirmed. Terms reference 28-day membership billing; earlier $95/$145 observations are historical.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.